SynBioBeta Speaker
Daniel Goodman
Postdoctoral Fellow, UCSF
UCSF
YEAR
25
May 2025, SynBioBeta
Speaker
A synthetic immunologist and computational biologist working at the intersection of genome engineering, immune cell therapy, and genetic design using generative models. Working at UCSF with Kole Roybal & Alex Marson on the next generation of T cell therapies for cancer and autoimmune disease. MIT Ph. D. alum from George Church's lab.
SynBioBeta 2025 - Session Speaker
Designing Cellular Medicines: Using High-Throughput Experiments and AI Approaches to Program Cells to Cure Disease
We now live in a world where genetically engineered cells are circulating people's bodies and warding off cancer. But the first approved cell-based medicines—such as CAR-T therapy—are just the beginning. In this session, we'll explore the next generation of programmable cellular medicines.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
2026
Event Updates